Skip to Content
 

News: Gynecologic Cancer

Chic Awearness event supports VUMC ovarian cancer research

Sunday, September 17th, 2017

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.

Cancer patient creates artwork for Radiation Oncology suite

Friday, August 11th, 2017

In her life, Jessi Zazu, 27, has toured the world as a musician in the group Those Darlins, recorded three studio albums, starred in music videos and exhibited her original artwork in individual and group art shows. With parents who are artists and a father and grandfather who played music, Zazu was destined to inherit […]

Conference to focus on link between viruses and cancer

Thursday, July 13th, 2017

The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses. To enlighten the public about these risks, the Prevent Cancer Foundation, in collaboration with Vanderbilt-Ingram Cancer Center (VICC), is sponsoring “Think About the Link,” a seminar […]

Blood type link to cancer survival

Friday, May 19th, 2017

Ovarian cancer is the fifth leading cause of cancer deaths among women in the United States. Last year more than 14,000 deaths were reported. Despite treatment advances, overall five-year survival after diagnosis remains abysmally low at 45 percent. ABO blood type has been linked to multiple diseases including pancreatic and ovarian cancer risk. Two small […]

Researchers seek best ways to increase HPV vaccination rates

Friday, May 12th, 2017

Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education. “HPV is the most commonly sexually transmitted infection in […]

National Cancer Institute’s Lowy details HPV virus research efforts

Thursday, February 2nd, 2017

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. […]

Vanderbilt-Ingram Cancer Center Supports National HPV Vaccination Efforts

Tuesday, January 17th, 2017

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. Recognizing a critical need to improve national vaccination rates for HPV, Vanderbilt-Ingram Cancer Center (VICC) is again uniting with […]

Alvarez named chair of Obstetrics and Gynecology

Friday, May 6th, 2016

Ronald David Alvarez, M.D., Ellen Gregg Shook Culverhouse Chair in the Division of Gynecologic Oncology and vice chair of the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham, has been named chair of the Department of Obstetrics and Gynecology at Vanderbilt University Medical Center. His appointment is effective Sept. 1. Alvarez […]

Vanderbilt-Ingram Cancer Center Encourages HPV Vaccination

Wednesday, January 27th, 2016

Contact: Dagny Stuart, (615) 936-7245 Dagny.stuart@vanderbilt.edu In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in urging increased HPV vaccination for the prevention of cancer. Experts at VICC, in collaboration with colleagues at the other cancer centers, recognize […]

New lead for ovarian cancer treatment

Friday, December 11th, 2015

Despite increasingly advanced treatments, nearly half the women who contract ovarian cancer will die within five years. Chemotherapy drug resistance significantly contributes to the high mortality rate. Understanding the processes that trigger tumor growth allows scientists to find better ways to treat this disease. Members of the laboratory of Hal Moses, M.D., previously identified the […]

Next Page »